PacWest Financial Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-5,315
Closed -$314K 85
2015
Q3
$314K Sell
5,315
-100
-2% -$6.34K 0.23% 73
2015
Q2
$349K Hold
5,415
0.25% 75
2015
Q1
$349K Buy
5,415
+200
+4% +$12.5K 0.25% 74
2014
Q4
$308K Buy
5,215
+400
+8% +$22.6K 0.22% 78
2014
Q3
$246K Buy
4,815
+60
+1% +$3K 0.18% 80
2014
Q2
$231K Buy
4,755
+200
+4% +$9.86K 0.17% 83
2014
Q1
$237K Hold
4,555
0.18% 82
2013
Q4
$242 Hold
4,555
0.07% 86
2013
Q3
$211K Buy
+4,555
New +$200K 0.18% 88

Other funds holding BMY

PacWest Financial Management's BMY Position: Q4 2015 in Review

PacWest Financial Management sold out of Bristol-Myers Squibb (BMY) in Q4 2015, closing a stake of 5,315 shares — an estimated $314K sold.

PacWest Financial Management first reported a position in BMY in Q3 2013 and held it in 9 quarters. The position peaked at $349K in Q2 2015. 1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

  • PacWest Financial Management reported no remaining Bristol-Myers Squibb position as of Q4 2015 after selling out during the quarter.
  • PacWest Financial Management sold 5,315 Bristol-Myers Squibb shares in Q4 2015, an estimated $314K.
  • PacWest Financial Management first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 9 quarters.
  • PacWest Financial Management's Bristol-Myers Squibb position peaked at $349K in Q2 2015.
  • 1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on PacWest Financial Management's 13F filing for Q4 2015, filed 15 Jan 2016.